Pulse Biosciences
(NASDAQ) PLSE
Pulse Biosciences Financials at a Glance
Market Cap
$1.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$751.00K
Net Income (TTM)
-$74.57M
EPS (TTM)
-$1.10
P/E Ratio
-23.83
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$26.40
Volume
257,621.161
Open
$27.06
Price
$26.40
Volume
257,621.161
Open
$27.06
Previous Close
$26.29
Daily Range
$25.87 - $27.20
52-Week Range
$12.56 - $31.00
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$26.40
Volume
257,621.161
Open
$27.06
Previous Close
$26.29
Daily Range
$25.87 - $27.20
52-Week Range
$12.56 - $31.00
Estimated Earnings Date
Aug 11, 2026
PLSE News
PLSE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pulse Biosciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
116
CEO
Paul A. LaViolette, MBA
Website
www.pulsebiosciences.comHeadquarters
Miami, FL 94545, US
PLSE Financials
Key Financial Metrics (TTM)
Gross Margin
-91.08%
Operating Margin
-10392.14%
Net Income Margin
-9929.03%
Return on Equity
-86.67%
Return on Capital
-87.25%
Return on Assets
-91.36%
Earnings Yield
-4.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
69.21M
Volume
257.62K
Avg. Volume
339.79K
Financials (TTM)
Gross Profit
-$684.00K
Operating Income
-$78.05M
EBITDA
-$74.10M
Operating Cash Flow
-$55.20M
Capital Expenditure
-$303.00K
Free Cash Flow
-$55.50M
Cash & ST Invst.
$68.32M
Total Debt
$7.16M
Pulse Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$401.00K
N/A
Gross Profit
$31.00K
N/A
Gross Margin
7.73%
N/A
Market Cap
$1.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$15.69M
N/A
Employees
116
N/A
Net Income
-$18.58M
-10.6%
EBITDA
-$18.90M
-14.4%
Quarterly Fundamentals
Total Cash
$68.32M
-42.7%
Total Debt
$7.16M
-16.6%
Accounts Receivable
$157.00K
N/A
Inventory
$206.00K
+586.7%
Long Term Debt
$5.53M
-22.9%
Short Term Debt
$1.63M
+15.7%
Return on Assets
-91.36%
N/A
Return on Invested Capital
-1.09%
N/A
Free Cash Flow
-$14.63M
-7.8%
Operating Cash Flow
-$14.60M
-7.9%